TSUJI Daiki

J-GLOBAL         Last updated: Nov 28, 2018 at 12:43
 
Avatar
Name
TSUJI Daiki
E-mail
d-tsujiu-shizuoka-ken.ac.jp
Affiliation
University of Shizuoka
Section
School of Pharmaceutical Sciences
Job title
講師

Research Areas

 
 

Published Papers

 
Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
Shimizu H, Suzuki K, Uchikura T, Tsuji D, Yamanaka T, Hashimoto T, Goto K, Matsui R, Seki N, Shimada T, Ikeda S, Ikegami N, Hama T, Yamamoto N, Sasaki T.
   2018   [Refereed]
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trial
Tsuji D, Suzuki K, Kawasaki Y, Goto K, Matsui R, Seki N, Hashimoto H, Hama T, Yamanaka T, Yamamoto N, Itoh K.
Support Care Cancer doi: 10.1007/s00520-018-4403-y      2018   [Refereed]
Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
Yokoi M, Tsuji D, Suzuki K, Kawasaki Y, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
Support Care Cancer   26 1505-1513   2018   [Refereed]
Hirai K, Shirai T, Suzuki M, Akamatsu T, Suzuki T, Hayashi I, Yamamoto A, Akita T, Morita S, Asada K, Tsuji D, Inoue K, Itoh K.
Clin Exp Allergy   47 1374-1382   2017   [Refereed]
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study
Tsuji D, Yokoi M, Suzuki K, Daimon T, Nakao M, Ayuhara H, Kogure Y, Shibata K, Hayashi T, Hirai K, Inoue K, Hama T, Takeda K, Nishio M, Itoh K.
Pharmacogenomics J.   17 435-440   2017   [Refereed]